ImmuniWeb® Continuous Penetration Testing vs Veria Labs: Side-by-Side Comparison (2026)
Features, pricing, ratings, and pros & cons — compared head-to-head.
ImmuniWeb® Continuous Penetration Testing is a commercial penetration testing tool by ImmuniWeb. Veria Labs is a commercial penetration testing tool by Veria Labs. Compare features, ratings, integrations, and community reviews side by side to find the best penetration testing fit for your security stack.
CST VerdictBased on our analysis of NIST CSF 2.0 coverage, core features, company size fit, deployment model, here is our conclusion:
ImmuniWeb® Continuous Penetration Testing
Security teams managing APIs and web applications with frequent code deployments will get the most from ImmuniWeb® Continuous Penetration Testing because it re-scans automatically after changes rather than waiting for quarterly assessments. The service covers NIST ID.RA and PR.PS effectively, meaning it maps both your risk posture and platform vulnerabilities into a continuous cycle. Skip this if your organization needs penetration testing bundled with incident response or threat hunting; ImmuniWeb stays narrowly focused on finding what changed and what broke, not on detecting active compromise.
Development teams shipping code faster than their security teams can audit it should evaluate Veria Labs for its ability to catch real vulnerabilities in pull requests before merge, not just flag suspicious patterns. The CI/CD integration and automated exploit proof-of-concept generation means your engineers see exploitable flaws with working examples, which actually changes remediation behavior. The tradeoff: with four people building this, you're betting on a young vendor, and runtime detection across your staging environment is only as good as your test coverage, so this works best paired with existing application security tooling, not as a replacement for it.
